Cognex Corporation (CGNX): what the price assumes

In the published model solve dated 2026-Q2, anchored at $62.26, Cognex Corporation (CGNX) is priced for today's economics sustained for ~13.6 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CGNX

Headline

FieldValue
TickerCGNX
CompanyCognex Corporation
Sector / IndustryTechnology
Current price$62.26/sh
CompositionStandard products and services 89% / Application-specific customer solutions 12%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)45.6%
Operating margin today21.9%
Margin expansion (value-band)+23.7pp
Must persist for13.6y
Multiple paid43x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 11.6% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history+0.48σ
cohort percentile (of 190 peers)75

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset5.16x5expensive
Earnings4.63x5expensive
Relative1.84x5expensive
Growth0.90x3justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.1%); the inversion above states its own rate.

Per-Model Detail (n=18)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$54.121.15xyesFCF base $0.3B, growth 17% (input: historical growth), terminal g 4.0%, WACC 9.1%, 6yr projection
DCF Exit MultipleGrowth$77.670.80xyesExit EV/EBITDA: 41.5x / 43.5x / 45.5x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$33.851.84xyesP/E 30.58x (blended: static sector reference 18x + trailing (TTM) 60x), scenarios: 25.1x / 30.6x / 36.0x (bear / base = reference held flat / bull), EV/EBITDA 21.45x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$11.235.54xyesBV/sh $9.69, ROE (TTM) 10.7%, ke 9.3%
Two-Stage Excess ReturnAsset$12.065.16xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$69.030.90xyesRev $1.1B, growth 17% (input: historical growth; tapered), Terminal P/S: 7.9x / 9.6x / 11.3x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$36.401.71xyesEPS $1.04, growth 35% (input: historical EPS growth), PEG=1.71 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$9.166.80xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.17B × (1−19%) / WACC 9.1% → EPV (no growth)
Residual IncomeAsset$12.225.09xyesBV $9.69 + 5yr PV of (ROE (TTM) 10.7% − Kₑ 9.3%) × BV; BV grows 7.0%/yr
Graham NumberAsset$15.064.13xyes√(22.5 × EPS $1.04 × BVPS $9.69) — Graham's conservative floor
EV/EBITDA RelativeRelative$16.733.72xyesEBITDA $0.24B × sector EV/EBITDA 12.0x
FCF YieldEarnings$16.633.74xyesFCF $268.3M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$13.454.63xyesSBC-adj FCF $0.22B (FCF $0.27B − SBC $0.05B) capitalized at Kₑ
Ben Graham FormulaEarnings$33.561.86xyesEPS $1.04 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$4.3014.48xyesBV $9.69 × (ROIC 4.0% / WACC 9.1%)
P/Sales SectorRelative$16.183.85xyesRevenue $1.09B × sector P/S 2.5x
PEG Fair ValueRelative$39.001.60xyesEPS $1.04 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$11.245.54xyesEPS $1.04 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$404.4m
Net debt / NOPAT (after-tax)-2.08x (net cash)
Net debt / operating income (pre-tax)-1.70x (net cash)
Share count CAGR (buyback)-0.7%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

A machine vision system is a camera bolted to a factory line. The camera is a commodity. What is not a commodity is the software that looks at the image and decides, in a few milliseconds and without a human, whether the part in front of it is right. That distinction is the whole moat, and it shows up in a single line of the latest quarterly filing: Gross margin was 71% for the three-month period in 2026 as compared to 67% for the same period in 2025, the improvement attributed to more favorable end-market mix and higher sales volume. For scale, TRMB files a gross margin of 69.5% and TER 58.7%, and both are well-run businesses. Cognex is selling code with a lens attached.

The company describes itself in the 10-K as a global technology leader in industrial machine vision systems, which is the kind of self-description every filer writes. The interesting part is what it is spending to stay there. Management states that a continued commitment to RD&E activities is essential to maintain or achieve product leadership and points to a move toward a unified software architecture across product lines. That architecture is the thing a customer gets locked into. A plant that has trained its engineers on one vision toolkit, written its inspection routines against it, and validated those routines with a regulator does not casually re-platform to save a few thousand dollars a station.

Then there is operating leverage, which for this business is unusually violent. Full-year 2025 saw operating income rise to 16% of revenue in 2025 compared to 13% of revenue in 2024 due to the leverage achieved from revenue growth on lower operating expenses, with net income of $0.68 per share for the year against $0.62 the year before. The first quarter of 2026 took that further, the 10-Q reporting that Operating income increased to 22% of revenue for the first quarter of 2026 as compared to 12% of revenue for the first quarter of 2025, on revenue up 21% before currency effects, with the increase attributed to broad-based demand across consumer electronics, semiconductor and other major end markets. When most of each incremental sales dollar survives the cost of goods, and the cost base underneath is largely salaried engineers, growth arrives at the operating line nearly intact.

The demand side has a slow, regulatory-shaped tailwind behind it. The 10-K argues that growth in packaging will be driven by increasingly stringent regulations around traceability, quality, and compliance, which is the sort of driver that does not care much about the business cycle. Somebody has to read the code on the box. Machine vision is how that gets done at line speed.

Capital allocation is unglamorous and consistent with the story. The board authorized a $500,000,000 repurchase program in March 2022, described in the filing as intended in part to offset dilution from employee stock awards, and the share count has fallen at roughly 1.2% a year over the four years to April 2026. There are no funded borrowings against the business. Total contractual obligations disclosed for the end of 2025 came to 93.4 million dollars, of which 15.8 million falls due within twelve months, set against $187.2M of trailing operating income. Whatever the bear argument turns out to be, and there is a real one, it is not an argument about whether this company survives a bad year.

Bear Case

The most candid competitive warning about Cognex is written by Cognex. The 10-K states that large technology companies and other competitors with substantial financial and technological resources may continue to develop and distribute free or low-cost solutions, and that the risk is to our ability to differentiate our products on performance or features. Read that slowly. The company's moat is a proprietary algorithm sold at a gross margin most hardware makers never approach, and the disclosed threat is that general-purpose vision models, trained by firms with vastly larger research budgets and given away to seed a platform, make "good enough" free. That is not a distant hypothetical in a field where the underlying technique has moved from hand-tuned pattern matching to trained networks in under a decade. The commodity part of the system was always the camera. The question the bear asks is whether the software is on its way to joining it.

That matters more than it normally would because of what the price assumes. At $62.06 the market is paying about 54 times company-wide operating income, which inverts to operating growth held at its self-funding ceiling for roughly 16 years. Not the growth rate: the rate is within what the business has recently delivered. It is the persistence. Of comparable fast-growers, only about 14% sustained that pace even a decade. The multiple itself sits at the very top of its peer distribution, well beyond the upper quartile. If the compounding runs six years instead of sixteen, the arithmetic does not soften gently, because each percentage point taken off the growth rate moves the required horizon by about 2.4 years in the other direction. The price would then have to find support from the earnings-power methods, which currently sit at roughly a fifth of it.

The cyclical exposure is real and recent. Full-year 2025 carried a gross margin decline that the filing attributes to a strategic product portfolio review under new leadership, reduced focus on certain legacy products with the attendant obsolescence risk, less favorable industry mix and tariffs. Revenue from customers based in Greater China fell 3% that year, and automotive weakness offset gains elsewhere. Roughly 67% of 2025 revenue came from customers outside the United States, so the reported line carries currency and trade policy along with demand. The 10-K also flags that the business experiences significant seasonal variations, with certain quarters typically generating higher revenues due to industry cycles and customer purchasing patterns, which is a caution worth holding next to a single spectacular quarter.

And the customer is the softest link in the chain. A factory-automation purchase is discretionary in timing even when it is not discretionary in principle. The filing spells it out: slower growth or recession, higher interest rates, tighter credit and labor shortages may cause companies to delay or reduce spending for automation projects. A vision system that pays back in eighteen months still gets deferred when the plant manager's capital budget is frozen, and the deferral shows up in Cognex's quarter, not the customer's.

None of this is a solvency argument, and the bear should not pretend otherwise. The company carries no funded borrowings and generates cash. The claim is narrower and harder to dismiss: sixteen years of uninterrupted compounding is being underwritten by a business whose demand arrives in cycles, whose largest single-country exposure declined last year, and whose own risk disclosure names free software as the thing that could take the margin away.

Valuation

At $62.06 on July 25, 2026, the market values the enterprise at about 54 times company-wide operating income. Run that backwards at an 11.6% cost of capital and it resolves into a duration: operating growth held at its self-funding ceiling of 25% a year for roughly 16 years. The rate is not the unusual part. Measured against what Cognex has recently delivered, that pace is inside its own recent range, and the first quarter of 2026 delivered revenue up 21% before currency effects. The unusual part is how long the price needs it to last, and the trade is steep in both directions: each percentage point off the growth assumption adds about 2.4 years to the horizon the price requires.

Two of the three reference points say the same thing about that duration. Against the sector, the multiple sits at the very top of the peer distribution, well beyond the upper quartile. Against the historical record of companies that grew this fast, only about 14% sustained the pace across a full decade. The horizon in the price is longer than that by half again.

The methods themselves split cleanly, and the split is the information. Only the forward-growth family reaches the price. Everything static falls well short: the asset-based lens sits at roughly a sixth of it, the earnings-power methods at about a fifth, and the peer-multiple family at a little under half. Nothing about that pattern is anomalous for a company whose value is a software franchise rather than a factory. Book value per share is $8.78, and a business whose main asset is code its engineers wrote will always look thin to a balance sheet method. But the way the growth models get there deserves naming. One capitalizes revenue on a terminal price-to-sales ratio held flat at today's level; the other carries today's enterprise-value-to-EBITDA ratio forward to the exit year without compressing it. Both reach the price by assuming the market's current opinion of this business is also its permanent one.

The cohort comparison sharpens it. On trailing operating margin, Cognex earns 18.5%, which places it in the middle of its comparison set rather than at the top: KEYS files 18.2%, TRMB 17.3%, MKSI 13.9%, and TER 26.5% on revenue nearly four times larger. On growth, TER filed 30.3% and KEYS 19.2%. So this is a company with peer-typical operating economics carrying a multiple that no peer carries. The premium is not being paid for demonstrated margin. It is being paid for the expectation that the margin structure and the growth rate hold together for a decade and a half, which is a claim about durability, not about the current year.

The balance sheet does what a clean balance sheet should do here, which is to remove one whole category of risk from the conversation. There are no funded borrowings. Total contractual obligations disclosed at the end of 2025 were 93.4 million dollars, of which 15.8 million falls due within twelve months, against $187.2M of trailing operating income and $142.5M of trailing net income. The share count has declined about 1.2% a year over the four years to April 2026, under the $500,000,000 repurchase program the board authorized in March 2022. Solvency is therefore not the variable in this name. Time is, and about sixteen years of it has already been spent.

Catalysts

The next scheduled information event is the second-quarter 2026 report on August 5, 2026. It matters more than a routine print because of what preceded it. For the quarter ended April 5, 2026 the 10-Q reports that Operating income increased to 22% of revenue for the first quarter of 2026 as compared to 12% of revenue for the first quarter of 2025 and that Gross margin was 71% for the three-month period in 2026 as compared to 67% for the same period in 2025, with the revenue increase attributed to broad-based demand across major end markets including consumer electronics and semiconductor. A single quarter of that shape can be mix. Two consecutive quarters start to look like the cost structure.

Sell-side positioning moved with the stock rather than ahead of it. Citi raised its price target to $72 from $68 on July 12, 2026 while keeping a Neutral rating, and Truist raised its target to $71 from $61 on July 1, 2026 while keeping a Hold. Neither house changed its rating, which is the useful detail: these are target revisions that follow a re-rated share price, not analysts arguing the business has changed.

The slower-burning item is internal. The 2025 annual filing describes a comprehensive strategic product portfolio review under a new leadership team, with a decision to reduce focus on certain legacy products that raised the risk of excess and obsolete inventory and contributed to that year's gross margin decline. The first quarter of 2026 suggests the pruning is now showing up on the favorable side of the mix. Whether that holds through a full year of comparisons is the thing to check on the August print and the one after it.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Cognex earnings-date announcement, July 16, 2026 · Cognex announcement of second-quarter earnings release and conference call dates, July 16, 2026 · TheFly, July 12, 2026 · TheFly, July 1, 2026

View the full interactive CGNX report on boothcheck